Lumoxiti
Active substance: moxetumomab pasudotox
moxetumomab pasudotox
Centralised EU authorisationWithdrawn
Marketing holder: AstraZeneca AB
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/005322
- Registration status
- Withdrawn
- ATC code
- L01X
Sources
- product · EMA · EMEA/H/C/005322 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/005322 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/005322 · Verified 2026-10-09